ASPHD1 and central nervous system cancer: The findings demonstrated that elevated levels of ASPHD1 expression was associated with extended OS in SKCM (Figure 5c), UVM (Figure 5d), MESO (Figure 5f), and low-grade glioma (LGG) (Figure 5e).